Elisabeth de Darkó
Career history of Elisabeth de Darkó
Former positions of Elisabeth de Darkó
| Companies | Position | Start | End |
|---|---|---|---|
| Yamanouchi Nordic | Chief Tech/Sci/R&D Officer | - | - |
| General Counsel | - | - | |
Valderm ApS
 Valderm ApS Pharmaceuticals: MajorHealth Technology Valderm ApS is focused on the development of the second generation anthracycline valrubicin for innovative once daily topical treatment of hyper proliferative skin diseases e.g. psoriasis. Preclinical studies have confirmed the anti-proliferative effect of valrubicin and an attractive safety profile upon repeated topical applications has been documented. The company was founded in 2003 and is headquartered in Lyngby, Denmark. | Chief Executive Officer | 2006-03-31 | - |
Statistics
International
| Denmark | 3 |
Operational
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| General Counsel | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Valderm ApS
Valderm ApS Pharmaceuticals: MajorHealth Technology Valderm ApS is focused on the development of the second generation anthracycline valrubicin for innovative once daily topical treatment of hyper proliferative skin diseases e.g. psoriasis. Preclinical studies have confirmed the anti-proliferative effect of valrubicin and an attractive safety profile upon repeated topical applications has been documented. The company was founded in 2003 and is headquartered in Lyngby, Denmark. | Health Technology |
| Yamanouchi Nordic |
- Stock Market
- Insiders
- Elisabeth de Darkó
- Experience
